Medtronic has announced that its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) System met safety endpoints and achieved 98.7% success rate in an international clinical trial.
The first-of-its-kind defibrillator has been designed for treating the dangerously fast heartbeat which may lead to sudden cardiac arrest (SCA).
Using a minimally invasive approach, the lead (thin wire) of the system is placed outside the heart and veins, under the breastbone (sternum) and will be connected to a device, which will be implanted below the left armpit.
